Spine Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion byTim AllenMarch 10, 2025
Regulatory Lipogems Announces Enrollment of the Final Patient in ARISE FDA Clinical Trials for Knee Osteoarthritis byJosh SandbergMarch 5, 2025
Spine Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device byJosh SandbergMarch 3, 2025
Spine Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial byJosh SandbergSeptember 25, 2024
Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Spine Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix® Spinal System byJosh SandbergJune 11, 2024
Recon Regulatory Top Stories Lipogems Announces Last Patient Enrolled in the U.S. FDA IDE Arise Study for the Treatment of Knee Osteoarthritis byTim AllenApril 10, 2024
Spine BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease byTim AllenApril 8, 2024
Spine Spineart Completes Enrollment in the BAGUERA® IDE Trial for Two-Level Cervical Disc Replacement byJosh SandbergMarch 8, 2024
Spine Top Stories Spineart Completes Enrollment In The BAGUERA®C IDE Trial For Single-Level Cervical Disc Replacement byJosh SandbergMarch 1, 2024
